Federal Banking Reform Could Unlock Cannabis Valuation Multiples
By Sheeba M. | May 28, 2026 Federal Banking Reform Could Unlock Cannabis Valuation Multiples TL;DR: Proposed federal banking access could enable institutional capital inflow and traditional equity financing, potentially driving 40-60% valuation expansion across the sector. The structural barrier constraining cannabis valuations isn’t revenue growth—it’s banking friction. Without federal banking access, cannabis operators pay […]
MSO Earnings Surge as State Legalization Accelerates
By Sheeba M. | May 28, 2026 MSO Earnings Surge as State Legalization Accelerates TL;DR: Multi-state operators reported record Q1 revenues, signaling sustained investor confidence despite federal headwinds. Watch TCNNF and CURLF for next earnings catalysts. The latest earnings season has delivered a stark message to cannabis markets: multi-state operators (MSOs) are capturing unprecedented revenue […]
Village Green Daily Brief — May 28, 2026
FROM THE VILLAGE GREEN Curated from social media posts and threads • Thursday, May 28, 2026 | 7:00 AM ET 280E Tax Relief Powers Multi-State Operators MSOs report 280E deduction eligibility after April 28 reclassification. Trulieve ($287M Q1), Curaleaf ($324M Q1), GTI ($300M Q1) post strong earnings. DEA Registration Floodgates Open Post-Reclassification Nearly 400 cannabis […]
Delta-9 Hemp Edibles Hit Inflection Point—Mass Market Entry Imminent
By Sheeba M. | May 27, 2026 Delta-9 Hemp Edibles Hit Inflection Point—Mass Market Entry Imminent TL;DR: Federal hemp legality + retail distribution agreements = $2B+ delta-9 edibles market by 2028; first-mover brands will capture 60%+ margin premium before commoditization. The delta-9 hemp edibles market just crossed a critical threshold. For the first time, major […]
International Cannabis Legalization Wave Accelerates MSO Expansion
By Sheeba M. | May 27, 2026 International Cannabis Legalization Wave Accelerates MSO Expansion TL;DR: Global legalization momentum creates unprecedented growth opportunities for U.S. MSOs; companies positioning for European and LATAM entry before 2027 will capture outsized valuations. The cannabis industry is witnessing a watershed moment. After years of cautious domestic positioning, multi-state operators are […]
Hemp CBD Market Undergoes Major Consolidation as Regulations Tighten
By Sheeba M. | May 27, 2026 Hemp CBD Market Undergoes Major Consolidation as Regulations Tighten TL;DR: FDA enforcement actions against unqualified CBD makers are accelerating industry consolidation—consolidation favors established brands with verified testing and supply chain transparency, creating a $5B+ market opportunity for compliant operators by 2027. The hemp-derived CBD market is entering a […]
Cannabis MSOs Post Strong Q1 Earnings Amid Market Consolidation
By Sheeba M. | May 27, 2026 Cannabis MSOs Post Strong Q1 Earnings Amid Market Consolidation TL;DR: Major cannabis multistate operators reported 15-20% revenue growth in Q1 2026, signaling renewed investor confidence and potential for margin expansion as state-level compliance costs decrease. The cannabis industry’s largest multistate operators (MSOs) are signaling strong recovery momentum as […]
Schedule III Reclassification: Why CBD Players Win Long-Term
By Sheeba M. | May 27, 2026 Schedule III Reclassification: Why CBD Players Win Long-Term TL;DR: FDA Schedule III reclassification of cannabis commoditizes flower but professionalizes CBD. Expect 40-60% margin expansion for pure-play CBD operators by 2027 as GLP-1 synergy plays emerge. The cannabis market faces a paradox. Flower commoditizes as supply grows. But CBD—long […]
Banking Reform Opens New Capital Doors for MSOs
By Sheeba M. | May 27, 2026 Banking Reform Opens New Capital Doors for MSOs TL;DR: Federal banking reform could unlock $3-5B in institutional capital for cannabis MSOs by Q4 2026. Multi-state operators sitting on cash now have alternatives to junk-rated corporate debt. For eight years, cannabis operators faced a brutal choice: grow with internal […]
FDA Hemp Delta-9 Crackdown: Winners and Losers in Q2 2026
By Sheeba M. | May 26, 2026 FDA Hemp Delta-9 Crackdown: Winners and Losers in Q2 2026 TL;DR: FDA enforcement against unregulated hemp-derived cannabinoids (Delta-9, HHC, THC-O) is accelerating. Licensed MSOs benefit from regulatory clarity, but Delta-8 and hemp derivative revenue will face 40-50% margin compression. This favors traditional cannabis operators like Curaleaf (CURLF) and […]